02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 16.47
+2.17%Forward multiples
Based on analyst estimates
- P/E forward
- 29.18x
- P/E 2026E
- 9.21x
- P/E 2027E
- 8.17x
- P/E 2028E
- 7.11x
- P/S forward
- 1.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 7.37x
- PEG TTM
- —
- Price / book
- 0.76x
- Price / sales
- 0.60x
- Price / cash flow
- 6.72x
Enterprise value
- Enterprise value
- HKD 87.9B
- EV / sales
- 1.21x
- EV / EBITDA
- 10.08x
- EV / EBIT
- 14.59x
- Market cap
- HKD 43.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026